본문으로 건너뛰기
← 뒤로

Correction: Toripalimab-based chemoimmunotherapy for unresectable sinonasal NUT carcinoma of the maxillary sinus: a case report.

증례보고 1/5 보강
Frontiers in immunology 📖 저널 OA 100% 2021: 2/2 OA 2022: 13/13 OA 2023: 10/10 OA 2024: 62/62 OA 2025: 810/810 OA 2026: 522/522 OA 2021~2026 2026 Vol.17() p. 1828382 OA
Retraction 확인
출처

Yu D, Lin L, Tan J, Wang X, Xie Y, Huang Z, Guo B

📝 환자 설명용 한 줄

[This corrects the article DOI: 10.3389/fimmu.2026.1763340.].

이 논문을 인용하기

↓ .bib ↓ .ris
APA Yu D, Lin L, et al. (2026). Correction: Toripalimab-based chemoimmunotherapy for unresectable sinonasal NUT carcinoma of the maxillary sinus: a case report.. Frontiers in immunology, 17, 1828382. https://doi.org/10.3389/fimmu.2026.1828382
MLA Yu D, et al.. "Correction: Toripalimab-based chemoimmunotherapy for unresectable sinonasal NUT carcinoma of the maxillary sinus: a case report.." Frontiers in immunology, vol. 17, 2026, pp. 1828382.
PMID 41929522 ↗

Abstract

[This corrects the article DOI: 10.3389/fimmu.2026.1763340.].

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기